Centaurus Financial’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$135K Sell
1,884
-69
-4% -$5.32K 0.01% 946
2025
Q4
$155K Sell
1,953
-334
-15% -$26.3K 0.01% 888
2025
Q3
$172K Sell
2,287
-247
-10% -$16.9K 0.01% 846
2025
Q2
$175K Sell
2,534
-239
-9% -$15.7K 0.01% 763
2025
Q1
$188K Sell
2,773
-931
-25% -$55.7K 0.01% 691
2024
Q4
$166K Sell
3,704
-2,445
-40% -$137K 0.01% 711
2024
Q3
$387K Sell
6,149
-534
-8% -$31.2K 0.02% 467
2024
Q2
$395K Sell
6,683
-8,633
-56% -$540K 0.03% 436
2024
Q1
$1.22M Sell
15,316
-74
-0.5% -$5.65K 0.09% 211
2023
Q4
$1.22M Buy
15,390
+301
+2% +$21.4K 0.09% 207
2023
Q3
$1.05M Buy
15,089
+117
+0.8% +$8.29K 0.09% 222
2023
Q2
$1.03M Buy
14,972
+7,088
+90% +$504K 0.09% 230
2023
Q1
$586K Buy
7,884
+1,463
+23% +$123K 0.05% 352
2022
Q4
$598K Sell
6,421
-2,085
-25% -$201K 0.06% 324
2022
Q3
$811K Buy
8,506
+1,097
+15% +$109K 0.08% 270
2022
Q2
$687K Sell
7,409
-2,593
-26% -$253K 0.07% 310
2022
Q1
$1.01M Sell
10,002
-1,223
-11% -$128K 0.08% 280
2021
Q4
$1.16M Buy
11,225
+212
+2% +$19.6K 0.09% 249
2021
Q3
$935K Buy
11,013
+186
+2% +$15.6K 0.08% 282
2021
Q2
$903K Buy
10,827
+4,374
+68% +$358K 0.08% 297
2021
Q1
$485K Sell
6,453
-3,893
-38% -$284K 0.05% 377
2020
Q4
$707K Sell
10,346
-531
-5% -$34.5K 0.07% 297
2020
Q3
$635K Sell
10,877
-9,232
-46% -$574K 0.09% 240
2020
Q2
$1.31M Sell
20,109
-605
-3% -$38.1K 0.19% 136
2020
Q1
$1.23M Buy
20,714
+3,777
+22% +$252K 0.25% 112
2019
Q4
$1.26M Sell
16,937
-13,936
-45% -$979K 0.18% 133
2019
Q3
$1.95M Sell
30,873
-5,454
-15% -$323K 0.3% 86
2019
Q2
$1.98M Buy
36,327
+34,697
+2,129% +$1.87M 0.31% 84
2019
Q1
$30.2K Buy
1,630
+1,387
+571% +$85.6K 0.18% 111
2018
Q4
$4 Buy
243
+239
+5,975% +$17.8K 0.03% 302
2018
Q3
$292 Sell
4
-9,189
-100% -$657K 0.05% 312
2018
Q2
$592K Buy
9,193
+5,294
+136% +$349K 0.08% 263
2018
Q1
$243K Buy
3,899
+681
+21% +$48.9K 0.06% 295
2017
Q4
$233K Buy
+3,218
New +$234K 0.06% 277

Other funds holding CVS

Centaurus Financial's CVS Position: Q1 2026 in Review

Centaurus Financial reduced its CVS Health (CVS) stake by 3.5% in Q1 2026, selling an estimated $5.32K and leaving 1,884 shares worth $135K. The position accounts for 0.01% of the portfolio, ranked #946.

Centaurus Financial first reported a position in CVS in Q4 2017 and has held it in 34 quarters since. The position peaked at $1.98M in Q2 2019. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Centaurus Financial held 1,884 shares of CVS Health worth $135K as of Q1 2026.
  • Centaurus Financial sold 69 CVS Health shares in Q1 2026, an estimated $5.32K.
  • CVS Health made up 0.01% of Centaurus Financial's portfolio in Q1 2026, its #946 holding.
  • Centaurus Financial first reported a position in CVS Health in Q4 2017 and has held it in 34 quarters since.
  • Centaurus Financial's CVS Health position peaked at $1.98M in Q2 2019.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Centaurus Financial's 13F filing for Q1 2026, filed 18 May 2026.